Meningiomas are extraaxial brain tumors derived from arachnoid cells of neural crest origin. They are found along the dural lining of the venous sinuses of the brain and skull base, locations where arachnoid cells are most plentiful. Thus, meningiomas are commonly found at the cerebral convexity, petrous ridge, sphenoid wing, tentorium, foramen magnum, cerebellopontine angle, and cavernous sinus. They comprise 20% of primary intracranial tumors and are identified more commonly in older patients and in women.
ROLE OF PREOPERATIVE ANGIOGRAPHY AND EMBOLIZATION

Pretreatment Imaging Evaluation
Initial imaging evaluation often involves obtaining a CT scan. Noncontrast CT scanning classically demonstrates a dural-based, homogeneous tumor of increased density compared with surrounding brain, with variable mass effect and surrounding edema. Hyperostosis of adjacent bone is a common feature of the meningioma. Contrast administration produces dramatic homogeneous enhancement of the tumor and often reveals a dural tumor tail.
With its multiplanar capabilities, MR imaging provides additional information and good soft-tissue differentiation. On T 1 -weighted MR images, the tumor is of equivalent signal intensity compared with surrounding brain, and T 2 -weighted MR imaging reveals that the tumor signal is slightly increased compared with normal brain, but less so than that of cerebrospinal fluid. Fluid-attenuated inversion recovery MR imaging highlights surrounding edema. With administration of Gd, MR imaging demonstrates homogeneous tumor enhancement. Absence of flow signal in an adjacent dural sinus may indicate that tumor invasion and occlusion of the sinus have occurred.
Neuroimaging findings suggestive of atypical meningioma include tumor inhomogeneity (either before or after contrast administration), tumor margin irregularity, rapid interval growth, abundant surrounding edema, and markedly enlarged internal tumor vessels. Such features should prompt consideration of other, less common diagnoses such as hemangiopericytoma or angiosarcoma.
Angiographic Evaluation
Angiography is not generally indicated unless embolization is planned. The classic angiographic appearance of a meningioma is that of increasing hypervascular tumor blush throughout the arterial phase, persisting well into the late venous phase with slow washout. Meningiomas are commonly supplied by dural arteries, which normally supply the covering of the brain. Such arteries include the MMA, accessory meningeal, ascending pharyngeal, or occipital transmastoid perforating branches of the ECA (depending on the location of the tumor). Dural arteries also include the tentorial and inferolateral trunk branches of the ICA, as well as the posterior meningeal branch of the VA. Secondary supply to a meningioma may be derived from pial branches (branches of the anterior, middle, and posterior cerebral arteries that supply the brain substance itself). Diagnostic angiography can also identify important information for the surgeon such as potential occlusion of a dural sinus adjacent to the tumor and the pattern of collateral venous drainage around such an occlusion.
Embolization Technique
The optimal treatment for meningiomas is complete resection, when possible. Factors that can hinder extirpation include tumor hypervascularity (which can complicate and lengthen the operation), encasement of major arteries or cranial nerves, and tumor involvement of a dural venous sinus. Embolization involves the devascularization of a tumor's blood supply through the placement of an embolic agent via a microcatheter into the feeding arteries. Because meningiomas are usually quite vascular, preoperative embolization (Figs. 1 and 2) can ease complete tumor resection by diminishing operative time and intraoperative blood loss. 8, 12 After a diagnostic arteriogram is obtained to identify blood supply and to assess safety and feasibility of embolization, a microcatheter (a small-lumen, flexible catheter) is navigated through the larger diagnostic angiography catheter and is directed over a microguidewire to the artery supplying the tumor. Real-time digital-subtraction fluoroscopy (so-called "road-mapping" technology) is essential for this maneuver. Superselective angiography is performed through the microcatheter to confirm its proper position and to identify any normal branches that might preclude safe embolization. 15 The following must be identified and examined to avoid potentially disastrous complications: the distal internal maxillary artery (potential communication with the ICA), the neuromeningeal trunk of the ascending pharyngeal artery (supply to ninth, 10th and 11th cranial nerves), the odontoid branch of the ascending pharyngeal artery (potential VA anastomosis), and the meningolacrimal branch of the MMA (potential retinal supply). Provocative testing by injection of a small-dose cardiac lidocaine through the microcatheter has also be used to identify blood supply to cranial nerves beyond the microcatheter tip. 9 The development of a temporary cranial nerve deficit after such a provocative test increases the risk of embolization and may warrant catheter repositioning before embolization. After the microcatheter has been properly and safely positioned, embolic material is injected under constant, real-time digital-subtraction fluoroscopy, to allow penetration of the material into the tumor bed, thereby producing devascularization and subsequent necrosis. A variety of embolic materials are available. In general, particulate agents (polyvinyl alcohol particles and acrylic microspheres 3, 4 ) are favored because of their relative ease of use, because the permanence of other agents such as liquid adhesive glue or ethanol is unnecessary in the preoperative setting, and because these liquid agents may easily penetrate small normal arteries below the resolution of fluoroscopic units. Overly vigorous embolization must be avoided because it can cause it can cause reflux of embolic material into normal proximal branches. After the tumor has been embolized, in some instances (usually when the MMA is involved), an occlusive microcoil can be placed into the feeding artery proximal to the tumor bed, permitting easier surgical transection of the artery. After the microcatheter is removed, postembolization angiography is performed to evaluate the angiographic completeness of embolization. Preoperative embolization of the pial meningioma supply, which usually represents secondary parasitized tumoral artery supply, is generally not conducted because the risk of stroke can be greater than the potential benefit of embolization. The timing of subsequent surgery has been debated. Some practitioners have reported that the timing of embolization has no effect on ease of tumor resection, 16 whereas others have advo- Fig. 1 . Contrast-enhanced axial CT scan obtained in a 59-yearold woman, revealing a well-circumscribed homogeneously enhancing meningioma based along the left frontal dural convexity. The lesion produces mass effect with midline shift and surrounding edema.
cated a delay of 7 to 10 days following embolization to allow tumor necrosis to occur and to simplify resection. 7, 13 
Outcomes and Complications
In the 1970s anecdotal reports of the efficacy of preoperative meningioma embolization were published; these were single case reports in which tumor resection after embolization was facilitated. 11, 19 Progressively larger patient series were subsequently described, 6, 8, 12, 16, 17, 20 providing evidence of angiographic, histological, and surgical efficacy of preoperative embolization. In a more recent report the authors have questioned the benefit of preoperative embolization. 5 In our view, preoperative embolization of meningiomas is standard treatment in centers offering endovascular therapy.
Palliative embolization has been undertaken as an alternative to definitive resection in patients considered suboptimal candidates for surgery, usually because of general medical condition. 6, 14 No large series to validate this treatment alternative, however, have been performed.
In properly selected cases, the risks of meningioma embolization are small and are related to the experience of the interventional neuroradiologist. 9 Anecdotal reports of complications, including tumoral 22 and subarachnoid 10 hemorrhage, scalp necrosis, 1 and retinal embolus 21 have been published. Other potential complications include transient cranial nerve palsies or inadvertent embolization of brain arteries through potential anastomoses of the ECA branches to the ICA or VAs.
CONCLUSIONS
The practice of preoperative embolization of meningiomas has evolved during the past two decades as a result of accrued experience and technical developments in micocatheters, imaging systems, and embolic materials. This procedure has become the standard of care in the treatment of this common tumor. 
